Key clinical point: The CMS Oncology Care Model is showing promise to improve care.
Major finding: Intervention group saw statistically significant improvement in 9 of 15 quality measures, most notably those pertaining to pain management, emotional distress, and documentation of advanced directives.
Study details: A quality improvement project involving 171 breast cancer patients and 33 clinical providers.
Disclosures: The study was supported by grants from the American Cancer Society and Genentech. Dr. Rocque reported support from Genentech and Pfizer.
Rocque G et al. J Oncol Pract. 2019. doi: 10. 1200/JOP.18.00390.